Background Mortality in coronavirus disease of 2019 (COVID-19) is associated with
increases in prothrombotic parameters, particularly D-dimer levels. Anticoagulation has …

(1) Background: Severe coronavirus disease can be complicated by a hypercoagulable
state in conjunction with sepsis, increasing the risk of venous thromboembolism. This study …

Background SARS-CoV-2 infection has noted derangements in coagulation markers along
with significant thrombotic complications. Post-mortem examinations show severe …

(1) Background: Severe coronavirus disease can be complicated by a hypercoagulable
state in conjunction with sepsis, increasing the risk of venous thromboembolism. This study …

Background Hospitalized patients with coronavirus disease 2019 (COVID-19) infection have
higher rates of venous thromboembolism (VTE). Higher mortality rates have been reported …

Background Observational studies have suggested a higher risk of thrombotic events in
patients with coronavirus disease 2019 (COVID-19). Moreover, elevated D-dimer levels …

Introduction Coronavirus disease (COVID-19) may induce a hypercoagulable state, leading
to microvascular and macrovascular thromboses, as shown in observational and autopsy …

Background COVID-19 infection is associated with D-dimer elevations, high rates of
thrombus formation, and poor clinical outcomes. We sought to determine if empiric …

Rationale: Elevated risk of thrombotic events is a major concern in patients with Coronavirus
Disease-2019 (COVID-19). Studies investigating these patients demonstrate high rates of …

Background COVID-19 is associated with hypercoagulability and increased incidence of
thrombosis. We compared the clinical outcomes of adults hospitalized with COVID-19 who …